USA, California
Market: Pharmacology, Financial services, Artificial Intelligence, Biotech, Defense/Military tech
Stage of the project: Prototype or product is ready
RexCrux is a symbolic AI platform using topology and entropy to predict structural change across biology, finance, and quantum systems.
Current Status
RexCrux has moved from development into active market validation. FoldShield++ benchmarks are running against clinically relevant protein targets with peer-reviewed submissions in progress. RainDrop has live models competing in the ADIA Lab Structural Break Challenge and Numerai Signals and Crypto, with validated production performance. QPhase is in active partnership discussions with a leading quantum hardware provider, supported by a complete technical specification and the development of federal research proposals.
Problem or Opportunity
The most consequential decisions in biotech, finance, and quantum computing rely on tools built for a simpler era. Drug candidates fail late in development. Portfolio models collapse at market turning points. Quantum programs run inefficiently on expensive hardware. These aren’t isolated failures — they share a common root: legacy infrastructure built for speed and scale, not structural precision. The cost is measured in failed therapies, lost capital, and delayed breakthroughs.
Solution (product or service)
RexCrux built a unified computational platform from first principles, powering three products: FoldShield++, which identifies protein structural failure modes before costly late-stage surprises; RainDrop, which detects market regime shifts that break conventional models; and QPhase, which optimizes quantum circuit compilation for real hardware. One shared engine drives all three — every deployment compounds the platform’s advantage and makes it more defensible over time.
Business model
RexCrux pursues staged commercialization across three platforms. Near-term revenue comes from competition outcomes and institutional consulting. As platforms mature, the model shifts to API licensing and SaaS — FoldShield++ for biotech and CROs, RainDrop for quant funds, QPhase for quantum teams. Long-term, co-development partnerships with pharma, financial institutions, and hardware manufacturers. One shared engine means expansion into new domains gets cheaper as the platform scales. RexCrux supports the b2b and b2b2c sectors.
